111 related articles for article (PubMed ID: 1632287)
1. Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis.
Pill J; Metz J; Stegmeier K; Hartig F
Agents Actions Suppl; 1992; 37():107-13. PubMed ID: 1632287
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
[TBL] [Abstract][Full Text] [Related]
3. Investigations of the antiatherosclerotic effect of the thromboxane A2 receptor antagonist Daltroban.
Pill J; Wolf O; Schmelz A; Stegmeier K; Metz J
Z Kardiol; 1990; 79 Suppl 3():155-60. PubMed ID: 2151550
[TBL] [Abstract][Full Text] [Related]
4. Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
Hood JS; Nossaman BD; Ibrahim IN; McMahon TJ; Babycos CR; Kadowitz PJ
J Appl Physiol (1985); 1992 Jun; 72(6):2305-10. PubMed ID: 1385804
[TBL] [Abstract][Full Text] [Related]
5. pH-dependent binding of the TXA2/PGH2-receptor of human platelet membranes to various ligands.
Theis JG; Dellweg H; Perzborn E; Gross R
Agents Actions Suppl; 1992; 37():222-7. PubMed ID: 1385924
[TBL] [Abstract][Full Text] [Related]
6. Atherosclerosis in the aorta of hypercholesterolemic rabbits and the influence of daltroban.
Metz J; Wolf O; Schmelz A; Pill J; Stegmeier KH; Hartig F
Exp Pathol; 1991; 41(2):57-69. PubMed ID: 1828033
[TBL] [Abstract][Full Text] [Related]
7. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Karasawa A; Shirakura S; Higo K; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of a thromboxane receptor antagonist (BM 13.505) on platelet hyperreactivity and thromboxane formation in cholesterol-fed rabbits.
Löbel P; Schrör E; Schrör K
Biomed Biochim Acta; 1988; 47(10-11):S86-9. PubMed ID: 3073772
[TBL] [Abstract][Full Text] [Related]
10. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
Yanagisawa A; Smith JA; Brezinski ME; Lefer AM
Eur J Pharmacol; 1987 Jan; 133(1):89-96. PubMed ID: 3030773
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2 alpha-induced sudden death in guinea-pigs and rats.
Shirakura S; Karasawa A; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1242-5. PubMed ID: 1815523
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug.
Stegmeier K; Pill J; Müller-Beckmann B; Schmidt FH; Witte EC; Wolff HP; Patscheke H
Thromb Res; 1984 Aug; 35(4):379-95. PubMed ID: 6385334
[TBL] [Abstract][Full Text] [Related]
14. Role of thromboxane in the altered vascular reactivity of pregnant rats with adriamycin nephropathy.
Mandelbaum A; Podjarny E; Bernheim J; Green J; Rathaus M
Nephrol Dial Transplant; 1999 May; 14(5):1124-8. PubMed ID: 10344349
[TBL] [Abstract][Full Text] [Related]
15. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
Arner M; Högestätt ED; Uski TK
Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
[TBL] [Abstract][Full Text] [Related]
16. Influence of SK&F 96148 on thromboxane-mediated responses in the airways of the cat.
Dyson MC; Kadowitz PJ
Eur J Pharmacol; 1991 May; 197(1):17-25. PubMed ID: 1909957
[TBL] [Abstract][Full Text] [Related]
17. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Patscheke H; Stegmeier K
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
[No Abstract] [Full Text] [Related]
18. 9, 11-Azo-12-oxa-15-hydroxyprostanoic acid: a potent thromboxane synthetase inhibitor and a PGH2/TxA2 receptor antagonist.
Kam ST; Portoghese PS
Prostaglandins Med; 1979 Nov; 3(5):279-90. PubMed ID: 233035
[TBL] [Abstract][Full Text] [Related]
19. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
de Chaffoy de Courcelles D; De Clerck F
Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
[TBL] [Abstract][Full Text] [Related]
20. Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest rat.
Bertolino F; Valentin JP; Patoiseau JF; Rieu JP; Colpaert FC; John GW
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):462-6. PubMed ID: 9349632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
